111 related articles for article (PubMed ID: 7552902)
1. Stability of ondansetron hydrochloride in a total parenteral nutrient admixture.
Kirkham JC; Rutherford ET; Cunningham GN; Daneshmand KA; Falls AL
Am J Health Syst Pharm; 1995 Jul; 52(14):1557-8. PubMed ID: 7552902
[No Abstract] [Full Text] [Related]
2. Stability of ondansetron and dexamethasone infusion upon refrigeration.
Rolin C; Hecq JD; Vanbeckbergen DF; Jamart J; Galanti LM
Ann Pharmacother; 2011 Jan; 45(1):130-1. PubMed ID: 21156815
[No Abstract] [Full Text] [Related]
3. Discoloration of parenteral ondansetron.
H Tsui BC; Cave D
Anesth Analg; 2003 Apr; 96(4):1239. PubMed ID: 12651705
[No Abstract] [Full Text] [Related]
4. Stability of ondansetron hydrochloride and five antineoplastic medications.
Stewart JT; Warren FW; King DT; Fox JL
Am J Health Syst Pharm; 1996 Jun; 53(11):1297-300. PubMed ID: 8725205
[No Abstract] [Full Text] [Related]
5. Stability of ondansetron hydrochloride and dexamethasone sodium phosphate in infusion bags and syringes for 32 days.
Hagan RL; Mallett MS; Fox JL
Am J Health Syst Pharm; 1996 Jun; 53(12):1431-5. PubMed ID: 8781690
[No Abstract] [Full Text] [Related]
6. Stability of cisplatin and ondansetron hydrochloride in admixtures for continuous infusion.
Henry DW; Marshall JL; Nazzaro D; Fox JL; Leff RD
Am J Health Syst Pharm; 1995 Nov; 52(22):2570-3. PubMed ID: 8590244
[No Abstract] [Full Text] [Related]
7. Stability of ondansetron hydrochloride and dexamethasone sodium phosphate in 0.9% sodium chloride injection and in 5% dextrose injection.
Evrard B; Ceccato A; Gaspard O; Delattre L; Delporte JP
Am J Health Syst Pharm; 1997 May; 54(9):1065-8. PubMed ID: 9143656
[No Abstract] [Full Text] [Related]
8. Ondansetron hydrochloride: a competitive serotonin 5-HT3 receptor blocker.
Mohan KC; Ravikumar K
Acta Crystallogr C; 1995 Dec; 51 ( Pt 12)():2627-9. PubMed ID: 8588861
[TBL] [Abstract][Full Text] [Related]
9. Compatibility of ondansetron hydrochloride and methylprednisolone sodium succinate in multilayer polyolefin containers.
Bougouin C; Thelcide C; Crespin-Maillard F; Maillard C; Kinowski JM; Favier M
Am J Health Syst Pharm; 2005 Oct; 62(19):2001-5. PubMed ID: 16174836
[TBL] [Abstract][Full Text] [Related]
10. X-ray diffraction and electron microscopy in the polymorphism study of ondansetron hydrochloride.
Llácer JM; Gallardo V; Delgado R; Párraga J; Martin D; Ruiz MA
Drug Dev Ind Pharm; 2001 Oct; 27(9):899-908. PubMed ID: 11763467
[TBL] [Abstract][Full Text] [Related]
11. Ondansetron: design and development of oral pharmaceutical suspensions.
Gallardo Lara V; Gallardo ML; Morales Hernandez ME; Ruiz Martinez MA
Pharmazie; 2009 Feb; 64(2):90-3. PubMed ID: 19320280
[TBL] [Abstract][Full Text] [Related]
12. Compatibility of granisetron hydrochloride with selected alkaline drugs.
Trissel LA; Martinez JF
Am J Health Syst Pharm; 1995 Jan; 52(2):208. PubMed ID: 12879553
[No Abstract] [Full Text] [Related]
13. Correction: chemical structures of serotonin and serotonin-receptor antagonists.
Holder EP
Ann Pharmacother; 1996 Sep; 30(9):1043. PubMed ID: 8876880
[No Abstract] [Full Text] [Related]
14. Physical and chemical stability of palonosetron hydrochloride with five common parenteral drugs during simulated Y-site administration.
Kupie TC; Trusley C; Ben M; Trissel LA
Am J Health Syst Pharm; 2008 Sep; 65(18):1735-59. PubMed ID: 18769000
[TBL] [Abstract][Full Text] [Related]
15. Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride.
Wu G; Yeung S; Chen F
Int J Pharm Compd; 2017; 21(1):76-82. PubMed ID: 28346200
[TBL] [Abstract][Full Text] [Related]
16. Stability of ondansetron hydrochloride, doxorubicin hydrochloride, and dacarbazine or vincristine sulfate in elastomeric portable infusion devices and polyvinyl chloride bags.
Stewart JT; Warren FW; King DT; Venkateshwaran TG; Ponder GW; Fox JL
Am J Health Syst Pharm; 1997 Apr; 54(8):915-20. PubMed ID: 9114924
[No Abstract] [Full Text] [Related]
17. [Pharmacokinetic and pharmacodynamic features of palonosetron].
Genazzani AA; Billington RA
Tumori; 2008; 94(2):suppl 6-13. PubMed ID: 18564620
[No Abstract] [Full Text] [Related]
18. Stability of granisetron hydrochloride in a disposable elastomeric infusion device.
Chung KC; Chin A; Gill MA
Am J Health Syst Pharm; 1995 Jul; 52(14):1541-3. PubMed ID: 7552896
[TBL] [Abstract][Full Text] [Related]
19. Rapidfilm: an innovative pharmaceutical form designed to improve patient compliance.
Reiner V; Giarratana N; Monti NC; Breitenbach A; Klaffenbach P
Int J Pharm; 2010 Jun; 393(1-2):55-60. PubMed ID: 20363308
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical development of ondansetron injection.
Leak RE; Woodford JD
Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S67-9. PubMed ID: 2533902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
